IL6 and Behcet disease: Studies have found increased serum levels of inflammatory markers such as interleukin (IL)-1, IL-6, tumor necrosis factor (TNF)α, soluble receptors of TNF, and IL-6 in BD patients (Benedetti et al., 2020).